, disease-causing mutations were discovered in the gene encoding the muscle sodium channel.
The channels conducting the sodium current during the action potential are surprisingly tissue specific, i.e., a whole family of closely related genes exists that code specifically for the sodium channels in nerve, skeletal muscle, and heart. These different sodium channels have in common that they are composed of two or three subunits of which the a-subunit constitutes the major functional part; it contains the pore, the voltage sensor, and the gates. All disease-causing sodium-channel mutations concern cu-subunit genes.
Before the gene encoding the a-subunit of the human adult skeletal muscle sodium channel, SCN4A, was cloned, an extensive electrophysiological survey, carried out with excised muscle specimens of all kinds from myotonia patients, had suggested that in two rare hereditary conditions the function of the sodium channels might be defective (10). is changed, such as the speed of current decay after a depolarization step, the current fraction that persists after the decay, the speed of the recovery from inactivation, the position of the steady-state inactivation curve, and/or the degree of uncoupling of inactivation from activation.
As it turned out, 14 of the 19 substitutions are situated in the "inactivating" linker between repeats Ill and IV (n = 5) or in repeat IV (n = 9), in particular, in the "voltage-sensing" segment S4 (n = 3 LQT-1 syndrome LQT-2 syndrome that two of the charged residues in IVS4 and presumably also the hydrophobic residues between them move from a position that is accessible from the intracellular space to one that is accessible from the outside (15).
Heart diseases trigger the search for cardiac ion-channel genes
The first heart diseases to be recognized as cardiac muscle channelopathies are the various forms of long Q-T syndrome (LQT) in which, as the name suggests, patients present with a prolonged Q-T interval of the electrocardiogram. were discovered in the intracellular loop between segments S4 and S5, the supposed acceptor for the inactivation particle, and in the sixth transmembrane domain (Fig. 1 B) .
LQT type 2 (LQT2) is also a potassium channelopathy ( Fig. I!? ). HE/K, the mutated gene, is located on chromosome 7q35-36 and is related to a Drosophila gene with the funny name ethera-go-go. The HERG product is a voltage-gated potassium channel that is also involved in cardiac repolarization.
Functional expression of HERG in Xenopus oocytes demonstrated that the channel has properties that resemble the delayed rectifier potassium channel in cardiac myocytes (5).
Finally, the most rare form, LQT type 3 (LQT3), was found to be a sodium channelopathy. The mutated gene SCNSA, located on chromosome 3~21-24, codes for the a-subunit of the major cardiac sodium channel (hH1). Analysis on the molecular level revealed mutations in domains that are homologous to those found mutated in skeletal muscle channelopathies: a deletion of three highly conserved amino acids (Lys, Pro, Gln) in the cytoplasmic linker between repeats III and IV, the inactivation gate, as well as point mutations in the interlinkers between segments 4 and 5 of repeats Ill and IV (Fig. 1 A) . Expression of the mutated gene in Xenopusoocytes revealed that the mutant channels conduct a persistent inward current that would explain the prolonged plateau phase of the cardiac action potential (2). With LQT now being more or less understood at the molecular level, there should be rapid progress in its treatment. Preliminary results suggest the use of sodium-channel blockers that have also proven successful in the management of muscle sodium channelopathies such as paramyotonia congenita.
Mutant neuronal potassium channels were found responsible for ataxia and myokymia Mutations in potassium-channel genes concern not only the heart but also the nervous system. The first neuronal channelopathy to be detected was episodic ataxia with myokymia. This autosomal dominant disease is characterized by episodes of failing excitation of cerebellar neurons and by permanent hyperexcitability of the second motoneurons.
The latter feature results in myokymia, the sustained twitching of motor units. The symptom responds to anticonvulsants such as carbamazepine.
Exercise may provoke brief attacks of atactic gait, and this can be prevented by acetazolamide. The disease is linked to Kv1.1 (located on chromosome 12pl3), the first of seven Shaker- (Fig. IB) . When the corresponding mutant cDNAs were expressed in Xenopus oocytes, four of the six products did not form functional channels (1). Because the wild-type allele is also expressed in vivo, the overall result of these mutations would just be a reduced potassium conductance.
In the remaining two cases, the mutant products formed channels with faster kinetics and increased C-type inactivation or with a shifted voltage dependence of activation (Phe-I 84-Cys). In all cases, the results are compatible with the notion that the affected nerve cells fire repetitively because reduction of the potassium current slows membrane repolarization.
Mutations in the skeletal muscle L-type calcium-channel gene cause defective excitation A rare disease that still poses queries both for clinicians and basic scientists is hypokalemic periodic paralysis. The disease, first described in 1727, is transmitted as an autosomal dominant trait. Clinically, it very much resembles hyperkalemic periodic paralysis described above as a sodium channelopathy.
The major symptoms of both diseases, i.e., episodes of generalized paralysis, may occur more frequently and be, on average, of shorter duration in hyperkalemic periodic paralysis, but there are many cases where a differential diagnosis requires considerable skill of the physician.
The two diseases may, of course, be discerned by the level of serum potassium during a paralytic attack, which may fall below 2 mmol/l in the former, whereas in the latter, it may rise beyond 4.5 mmol/l. 
